Concepedia

Howard L. McLeod

HL

Statistics

Publications

306

Citations

26.8K

H-Index

78

Active since

1987

Affiliations

Washington University in St. Louis(Current)

University of North Carolina at Chapel Hill

Moffitt Cancer Center

University of Aberdeen

Central South University

Howard L. McLeod is an author at Washington University in St. Louis specializing in medicine, pharmacology, and oncology.

Publications per year

1987–2025

306

Publications

306

Pharmacogenomics — Drug Disposition, Drug Targets, and Side Effects

William E. Evans, Howard L. McLeod · New England Journal of Medicine · 2003 · 1.8K citations

Medicine, Genetics, Pharmacology +17

Doxorubicin pathways

Caroline F. Thorn, Connie Oshiro, Sharon Marsh et al. · Pharmacogenetics and Genomics · 2010 · 1.6K citations · Full text

Life Sciences, Biology, Cell Signaling +1

Effect of <i>VKORC1</i> Haplotypes on Transcriptional Regulation and Warfarin Dose

Mark J. Rieder, Alex P. Reiner, Brian F. Gage et al. · New England Journal of Medicine · 2005 · 1.4K citations · Full text

Life Sciences, Genetics, Pharmacology +14

A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study

Jacob G. Scott, Anders Berglund, Michael J. Schell et al. · The Lancet Oncology · 2016 · 469 citations · Full text

Medicine, Oncology, Radiation Oncology +16

UGT1A1*28 Genotype and Irinotecan-Induced Neutropenia: Dose Matters

Janelle M. Hoskins, R. M. Goldberg, Peng Qu et al. · JNCI Journal of the National Cancer Institute · 2007 · 467 citations · Full text

Medicine, Hematology, Pharmacology +17

1–5 of 306